NCT06015633View on ClinicalTrials.gov

Ocular, Vascular, and Genetic Findings in AMD Patients

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

February 1, 2025

Study Completion Date

May 31, 2025

Conditions
Age-Related Macular Degeneration
Interventions
OTHER

No intervention

Observational only

Trial Locations (1)

Unknown

Tel Aviv Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

OcuDyne, Inc.
All Listed Sponsors
lead

OcuDyne, Inc.

INDUSTRY

NCT06015633 - Ocular, Vascular, and Genetic Findings in AMD Patients | Biotech Hunter | Biotech Hunter